Cytiva and Brooks Life Sciences enhance automation in cold chain solutions

Cytiva and Brooks Life Sciences, a division of Brooks Automation, are working together to expand Cytiva’s Chronicle software capabilities to integrate Brooks Life Sciences BioStore III automated storage platform. This has been purpose built to handle a range of high value materials between the temperatures of -20°C and -190°C in an efficient, documented way.

Chronicle software will provide a unified digital platform that can electronically trace cellular products and raw materials through the cell therapy workflow including the cryogenic cold chain.

Chronicle software has been designed to optimise complex cell therapy process development and manufacturing. It provides real-time supply chain tracking, hardware performance monitoring, SMS or email alarms, and comprehensive electronic batch manufacturing records (eBMRs). The eBMRs enable a manufacturer to define a sequence of eSOPs (electronic standard operating procedures), which are designed for specific processes to manage deviations, promote adherence to protocol, and provide guidance to ensure sensitive patient cells are handled appropriately.

Linda De Jesus, Vice President and Chief Commercial Officer Brooks Life Sciences, said: “By integrating a freezer platform like the BioStore III with Cytiva’s Chronicle software, we are helping customers add the documented rigor around cold chain, inventory and handling which previously did not exist. This integrated solution will allow customers to expand the role of automation in their workflows and documentation to help bring products to the market faster.”

Catarina Flyborg, Vice President, Cytiva, said: “Cell therapies are showing tremendous promise to transform human health, but the lack of automation is hampering manufacture and distribution. The integration of Chronicle software with Brooks Life Sciences BioStore III confirms the need for flexible solutions that can connect third-party instruments across complex manufacturing ecosystems.”

Image credit: Erin McKenna


Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free